205 related articles for article (PubMed ID: 35241678)
1. Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.
Lee M; Hamilton JAG; Talekar GR; Ross AJ; Michael L; Rupji M; Dwivedi B; Raikar SS; Boss J; Scharer CD; Graham DK; DeRyckere D; Porter CC; Henry CJ
Nat Commun; 2022 Mar; 13(1):1157. PubMed ID: 35241678
[TBL] [Abstract][Full Text] [Related]
2. The 'omics of obesity in B-cell acute lymphoblastic leukemia.
Geitgey DK; Lee M; Cottrill KA; Jaffe M; Pilcher W; Bhasin S; Randall J; Ross AJ; Salemi M; Castillo-Castrejon M; Kilgore MB; Brown AC; Boss JM; Johnston R; Fitzpatrick AM; Kemp ML; English R; Weaver E; Bagchi P; Walsh R; Scharer CD; Bhasin M; Chandler JD; Haynes KA; Wellberg EA; Henry CJ
J Natl Cancer Inst Monogr; 2023 May; 2023(61):12-29. PubMed ID: 37139973
[TBL] [Abstract][Full Text] [Related]
3. Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia.
Fei F; Zhang M; Tarighat SS; Joo EJ; Yang L; Heisterkamp N
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430839
[TBL] [Abstract][Full Text] [Related]
4. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
5. The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells.
Mazloum-Ravasan S; Madadi E; Fathi Z; Mohammadi A; Mosafer J; Mansoori B; Mokhtarzadeh A; Baradaran B; Darvishi F
Int J Biol Macromol; 2020 Mar; 146():193-201. PubMed ID: 31870867
[TBL] [Abstract][Full Text] [Related]
6. Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Pieters R; Kaspers GJ; van Wering ER; Huismans DR; Loonen AH; Hählen K; Veerman AJ
Recent Results Cancer Res; 1993; 131():249-56. PubMed ID: 8210644
[No Abstract] [Full Text] [Related]
7. MEF2D-rearranged acute lymphoblastic leukemia resembles Burkitt lymphoma/leukemia.
Sun J; Yu W; Zhang X
Ann Hematol; 2020 Jan; 99(1):185-188. PubMed ID: 31781846
[No Abstract] [Full Text] [Related]
8. Leukemic infiltrations of the peritoneum at diagnosis and the breast at relapse in a child with acute B-cell lymphoblastic leukemia.
Erduran E; Gedik Y; Orhan F; Reis A
Med Pediatr Oncol; 1999 Jan; 32(1):71-2. PubMed ID: 9917761
[No Abstract] [Full Text] [Related]
9. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
Khan NI; Bradstock KF; Bendall LJ
Br J Haematol; 2007 Aug; 138(3):338-48. PubMed ID: 17614820
[TBL] [Abstract][Full Text] [Related]
11. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
[TBL] [Abstract][Full Text] [Related]
12. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
13. The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.
Talby L; Chambost H; Roubaud MC; N'Guyen C; Milili M; Loriod B; Fossat C; Picard C; Gabert J; Chiappetta P; Michel G; Schiff C
Leuk Res; 2006 Jun; 30(6):665-76. PubMed ID: 16297978
[TBL] [Abstract][Full Text] [Related]
14. A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells.
Makishi S; Okudaira T; Ishikawa C; Sawada S; Watanabe T; Hirashima M; Sunakawa H; Mori N
Br J Haematol; 2008 Aug; 142(4):583-94. PubMed ID: 18503581
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.
Ito C; Ribeiro RC; Behm FG; Raimondi SC; Pui CH; Campana D
Blood; 1998 Feb; 91(3):1001-7. PubMed ID: 9446662
[TBL] [Abstract][Full Text] [Related]
16. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death.
van der Sluijs-Gelling AJ; van der Velden VH; Roeffen ET; Veerman AJ; van Wering ER
Leukemia; 2005 Oct; 19(10):1845-7. PubMed ID: 16107891
[No Abstract] [Full Text] [Related]
18. Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.
Bum-Erdene K; Collins PM; Hugo MW; Tarighat SS; Fei F; Kishor C; Leffler H; Nilsson UJ; Groffen J; Grice ID; Heisterkamp N; Blanchard H
J Med Chem; 2022 Apr; 65(8):5975-5989. PubMed ID: 35427125
[TBL] [Abstract][Full Text] [Related]
19. Linking the hematopoietic microenvironment to imatinib-resistant Ph+ B-ALL.
Dorshkind K; Witte ON
Genes Dev; 2007 Sep; 21(18):2249-52. PubMed ID: 17875661
[No Abstract] [Full Text] [Related]
20. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy.
Pramanik R; Sheng X; Ichihara B; Heisterkamp N; Mittelman SD
Leuk Res; 2013 May; 37(5):503-9. PubMed ID: 23332453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
